• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Engineered Viral Vector Enables Choroid Plexus Gene Editing Across Rodent Ventricles

by
November 10, 2026
in Health
Reading Time: 5 mins read
0
Engineered Viral Vector Enables Choroid Plexus Gene Editing Across Rodent Ventricles

Engineered Viral Vector Enables Choroid Plexus Gene Editing Across Rodent Ventricles

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a newly published investigation in Fluids and Barriers of the CNS, a research team led by John R. Pooley and colleagues has characterized a synthetic viral vector designated AAV2/ShH10Y445F that selectively targets the choroid plexus epithelium across mouse, rat, and porcine tissues. Beyond demonstrating cross-species cellular tropism in laboratory explant cultures, the authors utilized unilateral intracerebroventricular injections in adult female mice to introduce clustered regularly interspaced short palindromic repeats and Cas9 nuclease machinery, achieving targeted disruption and significant protein knockdown of the apical water channel aquaporin-1.

Comprising a single layer of polarized epithelial cells joined by continuous apical tight junctions, the choroid plexus forms a protective physical barrier with the cerebrospinal fluid compartment while continuously driving fluid production through active ion transport mediated by sodium-potassium ATPase and associated cotransporters. Because choroid plexus epithelial cells are post-mitotic and exhibit extremely slow cellular turnover, they offer an ideal cellular repository for durable, long-term therapeutic gene expression. Therapeutic interest has increasingly centered on targeting the apical water channel aquaporin-1, which governs transmembrane water permeability and has been implicated in cerebrospinal fluid hypersecretion following intraventricular hemorrhage.

Developing effective vector candidates for the choroid plexus epithelium requires surmounting significant biological barriers, notably avoiding off-target infectivity in adjacent ependymal cells that line the ventricular walls. The researchers addressed this selectivity challenge by engineering an adeno-associated virus capsid variant derived from serotype six, designated ShH10Y445F. To augment transduction potency, the authors integrated a rational tyrosine-to-phenylalanine substitution at position 445, an alteration known to help viral capsids evade ubiquitination and subsequent proteasomal degradation while reducing vulnerability to circulating neutralizing antibodies. When tested in primary explant cultures derived from mouse, rat, and pig choroid plexus, vector preparations packaging enhanced green fluorescent protein demonstrated marked epithelial tropism across all three species, showing detectable reporter signal by day two that intensified through day ten in culture.

To establish whether the engineered viral capsid retained its selectivity within an intact living mammalian nervous system, the investigators performed in vivo stereotactic microinjections into adult twenty-week-old female C57BL/6J mice. Using precise stereotactic coordinates one millimeter lateral and zero millimeters anterior-posterior relative to bregma, a volume of ten microliters containing 3.5 times ten to the tenth vector genomes was infused unilaterally into the left lateral ventricle at a controlled rate of 0.5 microliters per minute. Three weeks after infusion, histological examination of brain tissue sections revealed robust native green fluorescent protein expression localized within the choroid plexus epithelium directly underlying the injection site. Notably, while parenchymal cells situated along the surgical needle tract exhibited transgene expression due to direct tissue disruption, adjacent ependymal cells lining the lateral ventricular walls remained largely uninfected. Confocal microscopy confirmed that transduced choroid plexus cells were restricted to the outermost surface layer and expressed endogenous aquaporin-1 along their apical margins.

A crucial question in intraventricular drug delivery is whether a single unilateral injection can uniformly distribute viral particles throughout the interconnected chambers of the ventricular system. Systematic histological sectioning along the rostral-to-caudal axis revealed that vector distribution was highly heterogeneous following unilateral delivery. Within the injected left hemisphere, the strongest reporter fluorescence appeared not at the burr hole site itself, but between 0.8 and 1.0 millimeters caudal to the injection coordinates. Further posterior, at bregma minus 1.75 millimeters, fluorescent signal weakened considerably and was absent in a majority of the ventral horn choroid plexus. Viral particles did traverse the foramen of Monro into the contralateral hemisphere, establishing dorsal choroid plexus expression between minus 0.15 and minus 0.6 millimeters relative to bregma, though signal intensity remained substantially lower than on the injected side. Despite vector transit between lateral chambers, the third ventricle displayed minimal transduction with only scattered positive cells, whereas the more distal fourth ventricle exhibited modest but discernible transgene expression.

Having mapped baseline reporter expression, the team evaluated whether the vector platform could deliver functional gene-editing machinery to suppress endogenous protein expression. The researchers adapted a clustered regularly interspaced short palindromic repeats platform utilizing Cas9 nuclease from Staphylococcus aureus, paired with dual guide RNAs, designated 1B and 1E, targeted against exon one of the mouse aquaporin-1 gene. Following vector transfection, SURVEYOR mismatch endonuclease assays confirmed precise genomic cleavage at the targeted aquaporin-1 locus. Essential experimental negative controls—including an alternative green fluorescent protein vector, a modified construct lacking the U6 promoter and guide sequences, and a non-targeting guide construct verified against mouse, rat, and human genomes—exhibited zero target cleavage despite confirmed Cas9 protein expression.

Encouraged by successful in vitro genomic cleavage, the team advanced to in vivo therapeutic gene editing, escalating the injected viral payload to overcome the limited contralateral transduction observed in initial reporter trials. Adult mice received a unilateral intraventricular infusion containing 1.0 times ten to the eleventh vector genomes of a balanced one-to-one mixture carrying guides 1B and 1E. Six weeks following surgery, genomic DNA isolated from dissected choroid plexus was analyzed using the SURVEYOR assay to quantify insertion-deletion mutation frequencies. Both the injected and contralateral lateral ventricles demonstrated statistically significant genomic editing compared to uninjected control tissue, achieving statistical significance at p values below 0.001. Although the percentage of insertion-deletion mutations on the contralateral side was significantly lower than on the injected side with a p value of 0.017, the higher viral dose successfully drove contralateral editing to approximately two-thirds of the level measured in the injected hemisphere, demonstrating widespread genomic disruption.

To determine whether genomic disruption translated into measurable protein depletion, the authors quantified aquaporin-1 levels across serial coronal sections using quantitative confocal immunofluorescence. Six weeks after vector delivery, mice receiving the therapeutic mixture displayed significant protein knockdown that varied markedly according to anatomical location. Peak knockdown occurred in the dorsal lateral ventricle approximately 1.8 millimeters caudal to the injection site, where aquaporin-1 optical density dropped by seventy-eight percent on the injected side and fifty-four percent contralaterally. More rostrally, at 0.15 millimeters behind the injection, protein levels decreased by fifty-nine percent ipsilaterally and thirty-nine percent contralaterally. The ventral horns of the lateral ventricles demonstrated forty-five to forty-nine percent reduction. Within the third ventricle, significant knockdown of thirty-seven percent occurred rostrally at bregma minus 0.98 millimeters, but dropped to a non-significant twenty-six percent caudally, while fourth ventricle choroid plexus showed a negligible three percent reduction, confirming a steep rostro-caudal knockdown gradient.

The non-uniform distribution of gene editing and protein silencing across ventricular compartments provides critical insights into cerebrospinal fluid dynamics and physical vector dispersal. While initial models suggested that viral uptake by rostral choroid plexus simply dilutes vector concentrations down the ventricular stream, several empirical observations contradicted a simple linear dilution mechanism. Most notably, vector transduction was higher in the fourth ventricle margins than in caudal sections of the third ventricle, and higher in distal lateral ventral horns than in the proximal third ventricle. The authors propose that fluid dynamics and ventricular morphology dictate these disparities. The broad, sheet-like architecture of the lateral ventricles features slower fluid velocity and elevated hydrodynamic pressure, facilitating viral attachment and cellular entry. Conversely, the narrow third ventricle experiences accelerated fluid velocity and lower pressure, which may sweep viral capsids downstream before binding occurs. Regional variations in cell-surface receptor expression established during embryonic development may further modulate serotype-specific susceptibility across ventricles.

While these findings validate AAV2/ShH10Y445F as a potent vector for modifying choroid plexus epithelium, the researchers emphasized several experimental limitations and translational considerations essential for clinical development. The in vivo investigation was restricted to healthy adult female mice, leaving unresolved how altered ventricular architecture or neonatal developmental stages—where an incomplete ependymal lining can permit ventricular vector leakage—might alter biodistribution. Furthermore, the molecular receptors governing ShH10Y445F attachment in human and large animal choroid plexus remain to be characterized. Because clinical conditions such as post-haemorrhagic hydrocephalus may require extensive suppression of cerebrospinal fluid hypersecretion throughout all ventricles, overcoming anatomical delivery biases is imperative.

Subject of Research: Targeted adeno-associated virus gene delivery and CRISPR editing in choroid plexus epithelium

Article Title: Distribution of transgene in the rodent choroid plexus after intracerebroventricular injection of adeno-associated virus

Article References: Pooley, J. R., Bienemann, A. S., Young, A., Hollings, O., Wu, J., Mayo, E., Chu, C. J., & Singleton, W. G. B. (2026). Distribution of transgene in the rodent choroid plexus after intracerebroventricular injection of adeno-associated virus. Fluids and Barriers of the CNS, 23(1), Article 93. https://doi.org/10.1186/s12987-026-00831-4

Image Credits: AI Generated

DOI: 10.1186/s12987-026-00831-4

Keywords: adeno-associated virus, choroid plexus epithelium, CRISPR-Cas9, aquaporin-1, intracerebroventricular injection, cerebrospinal fluid dynamics, AAV2/ShH10Y445F, gene therapy, post-haemorrhagic hydrocephalus, ependyma, viral tropism, SURVEYOR assay, explant culture, SaCas9, ventricular system, target protein knockdown, capsid engineering, non-homologous end joining

News Source: Juliet Wilcox. (November 10, 2026). Engineered Viral Vector Enables Choroid Plexus Gene Editing Across Rodent Ventricles. Scienmag.

Tags: AAV2/ShH10Y445Fadeno-associated virusaquaporin-1capsid engineeringCerebrospinal Fluid Dynamicschoroid plexus epitheliumCRISPR-Cas9ependymaexplant cultureGene Therapyintracerebroventricular injectionnon-homologous end joiningpost-haemorrhagic hydrocephalusSaCas9SURVEYOR assaytarget protein knockdownventricular systemviral tropism
Share12Tweet7Share2ShareShareShare1

Related Posts

Early ICU Mobilization Aids Recovery While Sleep Evidence Remains Inconclusive

Early ICU Mobilization Aids Recovery While Sleep Evidence Remains Inconclusive

November 16, 2026
Urinary Extracellular Vesicles Connect Nutrient Stress to Kidney Inflammation in Diabetes

Urinary Extracellular Vesicles Connect Nutrient Stress to Kidney Inflammation in Diabetes

November 16, 2026

Epigenetic Profiling Identifies High-Risk Subgroup in Pediatric Adrenocortical Carcinoma

November 16, 2026

Angiotensin II Impairs Blood Clotting and Worsens Brain Bleeding in Mice

November 16, 2026

POPULAR NEWS

  • Higher Serum Uric Acid Associated With Obesity in Children With Tonsillar Hypertrophy

    Higher Serum Uric Acid Associated With Obesity in Children With Adenoid and/or Tonsillar Hypertrophy

    29 shares
    Share 12 Tweet 7
  • Clonal Haematopoiesis Associated With Elevated Cardiovascular Risk in MASLD Cohort

    29 shares
    Share 12 Tweet 7
  • Resting-state Brain Age Links Neurodevelopmental Burden to Schizophrenia Severity

    29 shares
    Share 12 Tweet 7
  • Low Preoperative Nutritional Index Predicts ICU Admission After Orthopedic Surgery

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Early ICU Mobilization Aids Recovery While Sleep Evidence Remains Inconclusive

Urinary Extracellular Vesicles Connect Nutrient Stress to Kidney Inflammation in Diabetes

Epigenetic Profiling Identifies High-Risk Subgroup in Pediatric Adrenocortical Carcinoma

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 87 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.